Company intelligence / Profile preview

ARCHIMED

Ownership: Private
Employees: ~201
Development stage: Other

Overview

ARCHIMED is a leading global private equity firm focused exclusively on healthcare industries, investing in sectors such as Biopharma Products, Diagnostics, Life Science Tools and Biologic Services, MedTech, Pharma Services, Healthcare IT, Consumer Health, and Animal & Environmental Health. It accelerates the growth and internationalization of healthcare businesses and manages €8 billion in funds, with a portfolio of companies achieving >20% average annual topline growth.[1][3][4][5]

Industry: Investors

Beyond the preview

Go deeper on ARCHIMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARCHIMED.